.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Teva
Colorcon
UBS
McKesson
Cantor Fitzgerald
Novartis
Healthtrust
Daiichi Sankyo
Dow
US Army

Generated: December 12, 2017

DrugPatentWatch Database Preview

Furosemide - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for furosemide and what is the scope of furosemide freedom to operate?

Furosemide
is the generic ingredient in two branded drugs marketed by Abraxis Pharm, Accord Hlthcare, Amneal Pharms Co, Astrazeneca, Baxter Hlthcare Corp, Emcure Pharms Ltd, Fresenius Kabi Usa, Hospira, Igi Labs Inc, Intl Medication, Luitpold, Marsam Pharms Llc, Smith And Nephew, Warner Chilcott, Watson Labs, West-ward Pharms Int, Wockhardt, Wyeth Ayerst, Sanofi Aventis Us, Dava Pharms Inc, Ipca Labs Ltd, Ivax Sub Teva Pharms, Kalapharm, Leading Pharma Llc, Mylan, Prinston Inc, Sandoz, Sun Pharm Inds Inc, Sun Pharm Industries, Superpharm, Watson Labs Teva, and Us Pharm Holdings, and is included in sixty NDAs. Additional information is available in the individual branded drug profile pages.

There are twenty-one drug master file entries for furosemide. Sixty-four suppliers are listed for this compound.

Pharmacology for furosemide

Medical Subject Heading (MeSH) Categories for furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Exclusivity Expiration
Prinston IncFUROSEMIDEfurosemideTABLET;ORAL076796-001Mar 26, 2004ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Baxter Hlthcare CorpFUROSEMIDEfurosemideINJECTABLE;INJECTION202747-001Jan 27, 2014APRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson LabsFUROSEMIDEfurosemideINJECTABLE;INJECTION070604-001Jan 2, 1987DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Leading Pharma LlcFUROSEMIDEfurosemideTABLET;ORAL077293-002Nov 9, 2005ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Watson Labs TevaFUROSEMIDEfurosemideTABLET;ORAL070528-001Jan 7, 1986DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
SandozFUROSEMIDEfurosemideTABLET;ORAL018569-001Approved Prior to Jan 1, 1982ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Dava Pharms IncFUROSEMIDEfurosemideTABLET;ORAL018415-002Jul 27, 1982DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
Abraxis PharmFUROSEMIDEfurosemideINJECTABLE;INJECTION019036-001Aug 13, 1984DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
West-ward Pharms IntFUROSEMIDEfurosemideTABLET;ORAL070086-001Jan 24, 1986ABRXNoNo► Subscribe► Subscribe► Subscribe► Subscribe
KalapharmFUROSEMIDEfurosemideTABLET;ORAL018868-002Jun 28, 1983DISCNNoNo► Subscribe► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: furosemide

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Sanofi Aventis UsLASIXfurosemideINJECTABLE;INJECTION016363-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm HoldingsLASIXfurosemideTABLET;ORAL016273-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm HoldingsLASIXfurosemideTABLET;ORAL016273-003Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Us Pharm HoldingsLASIXfurosemideTABLET;ORAL016273-002Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Sanofi Aventis UsLASIXfurosemideSOLUTION;ORAL017688-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Medtronic
Federal Trade Commission
Boehringer Ingelheim
Covington
Accenture
Merck
Express Scripts
Teva
Mallinckrodt
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot